Virus names database

Select sequence type: Protein Protein coding region Nucleotide Search for keyword: Keyword Search in strain name sequence pattern drug-resistance mutation How to use keywords? Full-length plus What is full-length sequences? Month Day. Collapse identical sequences. External link. The scheme uses the following format:.

When our analysts research a particular threat, they'll determine what each of the components of the name will be. Describes what the malware does on your computer. Worms, viruses, trojans, backdoors, and ransomware are some of the most common types of malware. Platforms indicate the operating system such as Windows, masOS X, and Android the malware is designed to work on.

The platform is also used to indicate programming languages and file formats. Grouping of malware based on common characteristics, including attribution to the same authors.

Security software providers sometimes use different names for the same malware family. It was extraordinary and should be emulated in the future, where it could be a model to focus research and funding on a specific, impactful topic. We have hired the first 50 BDPs, and we recently announced that we will be hiring another 50 BDPs, which is a massive investment. These new BDPs, along with paired junior faculty, will go into several clusters.

One of those nine clusters is a pandemic response and emergency preparedness PREP cluster, focusing on the areas of expertise that we saw were missing during our pandemic response and the areas that will continue to solidify us as the world's leader in pandemic response.

It's a very broad and ambitious vision that they're creating. I hope it will grow into a bigger pandemic institute. This is a way that we can really ensure that the investments we've put in these last two years turn into something that's lasting and momentous. Explore Vaccination Progress by U. Explore Vaccination Progress by Country. New Explore how U. By Chris Beyrer. By Larry Corey. For example, some of those doses are going to be targeted to India, which is facing a tragic surge in cases.

The idea is to get vaccines to where they are needed most. But it has to be done early. And then the third strategy is based on foreign policy decisions. This is my least favorite.

For example, the Biden Administration has donated doses to Canada and Mexico, obviously because they are countries on our borders where we have a self-interest in preventing virus importations. Is there enough time to deliver the vaccines to make a difference? Well, with India, I must say, it's late. Then you need to give them two doses. You can look at where outbreaks are really emerging like in Nepal or Thailand to target vaccine doses.

What more can the United States do to address the global situation? The United States needs to do a lot more than donating vaccines. The United States needs to support the expansion of vaccine manufacturing both domestically and abroad. It needs to help build that capacity, provide training for personnel, and relax export restrictions on supplies, reagents, and chemicals that go into manufacturing vaccines.

This needs to be a global partnership among the wealthy nations to coordinate all of the responses needed. We need to substantially reduce the burden of disease for humanitarian purposes and reduce transmission of the virus for self-interest to prevent the emergence of variants that could cause outbreaks in the United States. We are already at a point in the United States where we have a surplus of vaccines. Obviously we expanded eligibility for children 12 to 15 years old, and this will increase our need.

To date 1. This needs to be an urgent and collaborative global effort. Can surplus vaccines be used as booster shots later? I believe that is one of the reasons why there has been some reluctance to donate a large number of doses.

Many experts believe we will need them. The question is when. The Biden Administration justifiably has been focused on bringing the pandemic under control in the United States. It does not want to put the United States into a shortage, which I think is reasonable.

But the United States still need to be a global leader in addressing global vaccine inequities. The United States will need to maintain a supply of vaccine for potential booster doses.

Now if there is a new variant that is driving the need for additional vaccine doses, we could use the current vaccine as a booster, but we may also need a new vaccine created specifically to target a variant.

Pandemic Data Initiative. This is one of the greatest scientific and medical achievements in recent history, but detailed vaccination data reveals that this rollout has not been without its shortcomings.